DOCSLIB.ORG

NNN Conference 2019 - Delegate List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NNN Conference 2019 - Delegate List NNN Conference 2019 - Delegate List Country of Title First Name Last Name Organisation on Badge* Residence* Mr. ELIJA AKYENAAMPOFO ACCP Ghana Mrs. RITA ABEKAHFORDJOUR ACCP Ghana Mr. HARDI MOHAMMED SANIACCP Ghana Mrs. BENEDICTTASMART NAA ASAMANUAH ABBEYACCP Ghana Dr. Saba Lambert ALERT / LSHTM Ethiopia Mrs. Busime Mudekereza Amani Global Works United States Dr. Jacques Sebisaho Amani Global Works United States Miss Rita Aimiuwu Amen Foundation Nigeria Dr. Shyamala Anand American Leprosy Missions India Dr. Sunil Anand Dara American Leprosy Missions India Mrs. Melissa Edmiston American Leprosy Missions United States Mr. George Gitau American Leprosy Missions Kenya Dr. Annamma John American Leprosy Missions India Dr. Paul Saunderson American Leprosy Missions Norway Dr. Sundeep ChaitanyaVedithi American Leprosy Missions United Kingdom Mrs. Stefanie Weiland American Leprosy Missions United States Mr. Eroll Wekesa American Leprosy Missions Kenya Mrs. Leslie Zolman American Leprosy Missions United States American Leprosy Missions Mr. Martin Muchangi Amref Health Africa Kenya Mr. Getachew GebreselassieNida Amref Health Africa Ethiopia Mr. Peter Waka Amref Health Africa Kenya Ms. Arantzazu Jorge Quintana Anesvad Foundation Spain Dr. Gabriel Diez Anesvad Foundation Spain Mrs. Nicole Vecchio APPG on Malaria and NTDs United Kingdom Dr. John Amuasi ARNTD Ghana Dr. Olivier Weil ASCEND - Mott MacDonald France Prof. David Ascher Baker and Bio21 Institutes Australia Ms. Kate Okonkwo Banner Over African TroublesUnited (BOAT) Kingdom Dr. Khumbo Kalua BICO Malawi Dr. Katherine Owen BMGF United States Dr. Wldibb Dibb Bon Secours Health Ireland Dr. Kebede Deribe Brighton and Sussex MedicalEthiopia School Ms. Arianne Shahvisi Brighton and Sussex MedicalUnited School Kingdom Ms. Mary Ellen Sellers Canadian Network for NTDs Canada Ms. Stephanie Akweyu CBM Kenya Ms. Theresa Baird CBM United Kingdom Mr. Nicholas Burn CBM United Kingdom Mr. Matthew Hanning CBM United Kingdom Mr. Jan-Thilo Klimisch CBM Germany Prof. Dr.KH Martin Kollmann CBM Kenya Dr. Jean Lebon SAFARI BUHENDWACBM MWANDULO DR Congo Ms. Kirsty Smith CBM United Kingdom Mr. Johan Willems CBM Germany Mr. Wubante Yalew CBM Ethiopia Mrs. Sonja Mund CBM Germany Dr. Julian Eaton CBM / LSHTM United Kingdom Dr. Tania Crucitti Centre Pasteur du CamerounCameroon Mr. Francisco JavierSancho Mas Chagas Disease Coalition Spain Ms. Tara Seethaler CHAI United States Country of Title First Name Last Name Organisation on Badge* Residence* Dr. Rubina Imtiaz Children Without Worms United States Mrs. Juliana Amanyi Christian Blind Mission Uganda Mrs. Esther Bature Christian Blind Mission Nigeria Dr. Muhammad BabarQureshi Christian Blind Mission United Kingdom Mr. Soumana Zamo Christian Blind Mission Niger Dr. Mohamad Assoum CIFF United Kingdom Ms. Lilies Njanga CIFF Kenya Dr. Rita Oliveira CIFF United Kingdom Stephen Maud Cloud Nine Media United Kingdom Bruna Amaral Cloud Nine Media United Kingdom Mr. Xavier Badia Rius CNTD, LSTM United Arab Emirates Ms. Jan Douglass CNTD, LSTM Australia Miss Deborah Edwards CNTD, LSTM United Kingdom Dr. Louise Kelly-Hope CNTD, LSTM United Kingdom Hayley Mableson CNTD, LSTM United Kingdom Ms. Sarah Martindale CNTD, LSTM United Kingdom Brent Thomas CNTD, LSTM United Kingdom Dr. Adrian Hopkins Consultant United Kingdom Dr. Nkeiruka Orji COOU Nigeria Dr. TITO TRESORMELACHIO TANEKOUCRID Cameroon Mrs. Kate Wilson HargreavesCrown Agents United Kingdom Dr. Isam Eldin AwadSalah CSSW United States Mr. Thomas Collein DAHW Germany Mr. GADAH YAWOVI AGBENYIGANDAHW Togo Ms. Valeria Ramiconi Damien Foundation Belgium Dr. Patrick Suykerbuyk Damien Foundation Belgium Dean of LSTM United Kingdom Dr. Mohammad JahirulKarim DGHS Bangladesh Mr. Matthew Little Diamond Jubilee Trust United Kingdom Mr. Markus Hesse Direct Impact Group Germany Dr. Nathalie Strub-Wourgaft DNDi France Prof. Dr.Eduard Zijlstra DNDi Netherlands Annette Hornung-PickertDNTDs Germany Mr. Harald Zimmer DNTDs / vfa Germany Dr. Julien Ake Ake effect:hope Cote d'Ivoire Mr. Peter Derrick effect:hope Canada Ms. Kimberly Evans effect:hope Canada Sara Marshall effect:hope Canada Mr. Maneesh Phillip effect:hope Canada Dr. Fabian Gusovsky Eisai Inc. United States Mr. ASM Sultan Mahmood ELF Programme Bangladesh Dr. Matthew Freeman Emory University United States Prof. Deborah McFarland Emory University United States Ms. Jessica Rodgers Emory University United States Dr. Patricia Graves EpiVec Consulting United States Dr. Wendy Van de Sande ErasmusMC Netherlands Dr. Suzy Campbell Evidence Action Australia Mr. Subhash Khatri Evidence Action India Mr. Chrispin Owaga Evidence Action Kenya Mr. Brett Sedgewick Evidence Action United States Ms. Katherine Williams Evidence Action United States Mr. Gilbert Baayenda Federal Ministry of Health Uganda Mr. Segni Bobo Barkesa Federal Ministry of Health Ethiopia Country of Title First Name Last Name Organisation on Badge* Residence* Mr. Lazarus Juziwelo Federal Ministry of Health Malawi Mr. Karsor Kollie Federal Ministry of Health Liberia Dr. YOUSSOUPHANDIAYE Federal Ministry of Health Senegal Dr. Obiageli Nebe Federal Ministry of Health Nigeria Mr. Nebiyu Negussu Federal Ministry of Health Ethiopia Dr. Nicholas Olobio Federal Ministry of Health Nigeria Mr. Wyckliff Omondi Federal Ministry of Health Kenya Dr. Isaac Phiri Federal Ministry of Health Zimbabwe Dr. Mwatha Stephen Federal Ministry of Health Kenya Dr. Hadley Sultani Federal Ministry of Health Kenya Dr. BATCHO WILFRID ETIENNEFederal Ministry of Health Benin Rachel Bronzan FHI360 United States Mr. Achille Kabore FHI360 Burkina Faso Mr. Ernest Mensah FHI360 Ghana Stephanie Palmer FHI360 United States Mr. Justin Tine FHI360 Ghana Dr. Chukwuma ANYAIKE FMOH Nigeria Prof. Gail Davey Footwork United Kingdom Ms. Esther Garibay Footwork United Kingdom Dr. SARAH JAYME GARC Philippines Jeffrey French Gates Foundation United States Ms. Kitty Harding Gates Foundation United States Dr. Isaac Chikwanha GHIT Fund Japan Mr. Franz Xaver Wiedemann GIZ Togo Mr. Daniel Pawson Global Health Strategies United States Katharina Klohe Global Schisto Alliance Germany Dr. Anouk Gouvras Global Schistomiasis AllianceUnited Kingdom Miss Kelly Bridges Global Water 2020 United States Ms. Chinwe ChikaEze GLRA Nigeria Mr. Cyril W. Johnson GLRA Sierra Leone Dr. Christa Kasang GLRA Germany Dr. Vivek Lal GLRA India Dr. Anthony Meka GLRA Nigeria Grace PatrickMwasuka GLRA Tanzania Mrs. Tijana Williams GSK United Kingdom Mr. Christopher Ogoshi HANDS Nigeria Mrs. Christelly Badila Helen Keller International Guinea Dr. Guindo Boubacar Helen Keller International Mali Dr. Benoit Dembélé Helen Keller International Senegal Ms. Medoune Diop Helen Keller International Senegal Mr. Jean Paul Djiatsa Helen Keller International Burkina Faso Mr. OUEDRAOGOHamado Helen Keller International Burkina Faso Ms. Jennifer Harding Helen Keller International Tanzania Dr. Modibo KEITA Helen Keller International Mali Mr. Nick Kourgialis Helen Keller International United States Mr. Chad MacArthur Helen Keller International United States Mr. YATTARA MOHAMED LAMINEHelen Keller International Mali Mr. Aliyu Mohammed Helen Keller International Nigeria Dr. Dieudonné NARE Helen Keller International Burkina Faso Philomena Orji Helen Keller International Nigeria Dr. Steven Reid Helen Keller International United States Ms. Amy Veinoglou Helen Keller International United States Yaobi Zhang Helen Keller International United Kingdom Country of Title First Name Last Name Organisation on Badge* Residence* Prof. Philippe Guerin IDDO India Dr. Julia Halder IDDO United Kingdom Miss Brittany Maguire IDDO United Kingdom Prof. Roderick Hay IFD United Kingdom Mr. Mathias Duck Enns ILEP Paraguay Mr. Geoff Warne ILEP Switzerland Dr. May Sule Imperial College London United Kingdom Ms. Roosmarij Geutjes InfoNTD Netherlands Mrs. Aparna Adams International Coalition for TrachomaUnited KingdomControl Mr. Timothy Jesudason International Coalition for TrachomaUnited KingdomControl Miss Haregewoin MamoDesta IOCC Ethiopia Mr. Abebe KelemeworkTakele IOCC Ethiopia Mr. Sumon Ray ITI United States Dr. Teshome GebreKanno ITI / TFGH Ethiopia Ms. Ana Bakhtiari ITI / Tropical Data United States Dr. Gretchen Stoddard IZUMI Foundation United States Ms. Yuko Yoshida IZUMI Foundation United States Dr. Robert Geneau KCCO South Africa Miss Rosemary Musuva KEMRI Kenya Dr. Doris NJOMO KEMRI Kenya Mr. HARRAN MKOCHA Kongwa Tracgoma Project Tanzania Dr. Rabindra Baskota LCDMS Nepal Mr. Paul Watson Lepra United Kingdom Dr. Aparna Srikantam LEPRA / BPHRC India Mr. Kamalesh ChandraLal LEPRA Society India Mr. Sathiraju Marella LEPRA Society India Mr. Jayaram Parasa LEPRA Society India Mr. Naveen KumarSatle LEPRA Society India Mr. Rajni Kant Singh LEPRA Society India Jessica Ann FBlijkers Light for the World Austria Jacqueline Bungart Light for the World Austria Mr. Cyrille ThierryEVINI Light for the World Cameroon Solomon GadisaGeresu Light for the World Ethiopia Adugna Amin Mohammed Light for the World Ethiopia Jorge Cano LSHTM United Kingdom Mr. David Kennedy LSHTM United Kingdom Mr. Hugo Legge LSHTM United Kingdom Dr. William Oswald LSHTM United Kingdom Dr. Mateo Prochazka LSHTM United Kingdom Rachel Pullan LSHTM United Kingdom Dr. Benn Sartorius LSHTM United Kingdom Ms. Hope Simpson LSHTM United Kingdom Dr. Joseph Timothy LSHTM United Kingdom Dr. Emma Harding-Esch LSHTM / Tropical Data United Kingdom Miss Thais Caprioli LSTM United Kingdom Mrs. Laura Corbridge LSTM United Kingdom Mrs. Laura Dean LSTM United Kingdom Mrs. Joan Fahy LSTM United Kingdom Mrs.
Load more

Recommended publications
  • 1. General Information
    Reference: 2011/00520/FR/01/01 03/05/2013 EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HUMANITARIAN AID AND CIVIL PROTECTION – ECHO SINGLE FORM FOR FINAL REPORT 1. GENERAL INFORMATION UNDP-USA 1.2 Title of the Action Strengthening local capacities for response and management of risks with respect to seismic events in the Provinces of Puerto Plata and Santiago, Dominican Republic. 1.3 Area of intervention (country, region, localities) World Area Countries Region America DOMINICAN REPUBLIC Cibao Region: Puerto Plata y Santiago Provinces 1.4 Start date of the Action Start date 01/07/2011 If the Action has already started explain the reason that justifies this situation (urgent Action or other reason) NA 1.5 Duration of the Action in months 18 0 months days 1.6 Start date for eligibility of expenditure Is the start date for eligibility of expenditure equal to the date of submission of the initial proposal? No If yes, explain expenses charged to the budget between date of initial proposal submission and start date of the action If no, enter the start date for eligibility and explain 01/07/2011 NA 1.7 Requested funding modalities for this agreement Multi-donor action In case of 100% financing, justify the request 1.8 Urgent action No If Yes: In case of urgent action in the framework of another ECHO decision, Please justify 1.9 Control mechanism to be applied P 1.10 Proposal and reports Submission date of the initial proposal 15/04/2011 Purpose of this submission FINAL REPORT Agreement number: ECHO/DIP/BUD/2011/92008 page 1/69 Reference: 2011/00520/FR/01/01
    [Show full text]
  • The Business Response to Remedying Human Rights Infringements: the Current and Future State of Corporate Remedy
    The business response to remedying human rights infringements: The current and future state of corporate remedy Human Rights Remedy | June 2018 Australian Business Pledge against Forced Labour i Table of contents 1. Executive summary ...................................................................................................................................................... 1 2. Introduction .................................................................................................................................................................. 2 2.1 About this Report .................................................................................................................................................. 2 3. Context ......................................................................................................................................................................... 3 3.1 The Remedy Challenge ........................................................................................................................................ 3 4. Existing frameworks and guidance on the provision of remedy ................................................................................... 4 4.1 International Frameworks and Guidance ............................................................................................................. 5 5. Legal Context ..............................................................................................................................................................
    [Show full text]
  • PARTNERING for DIAGNOSTIC EXCELLENCE ANNUAL REPORT 2017 Our Vision a World Where Diagnosis Guides the Way to Health for All People
    PARTNERING FOR DIAGNOSTIC EXCELLENCE ANNUAL REPORT 2017 Our vision A world where diagnosis guides the way to health for all people Our mission Turning complex diagnostic challenges into simple solutions to overcome diseases of poverty and transform lives CONTENTS Leadership Message 4 2017 in Numbers 5 Key Achievements in Country Offices 6 Taking Stock: Mid-Term Strategy Review 9 Taking Action Catalyse Development 10 Guide Use & Inform Policy 12 Accelerate Access 13 Shape the Agenda 15 Spotlight on Diseases Fever, AMR & Outbreaks 16 Hepatitis C 18 Malaria 19 Neglected Tropical Diseases 21 Tuberculosis 22 Governance 23 2017 Financial Statements 26 LEADERSHIP MESSAGE Dr Catharina Boehme Mark Kessel Chief Executive Officer Chair of the Board The year 2017 marks the halfway point in diagnostic tests are quality assured. the delivery of our 2015–2020 strategy. We continue to contribute to global We are on track, as confirmed by an research: this year we published external mid-term review, and we enter 65 peer-reviewed manuscripts, and the second half of this strategic period collaborated with WHO to develop with renewed energy and concrete plans target product profiles for new tests, as for further portfolio strengthening. well as in-depth landscape reports and market analyses of diagnostic products. In the past year, more than 15 million For TB, we provided data to support FIND-supported products were provided the WHO recommendation of the Xpert to simplify diagnosis in low- and middle- MTB/RIF Ultra assay, which will advance income countries. We added 9 in vitro TB diagnostic capabilities in difficult-to- diagnostic projects to our portfolio, diagnose populations, such as children bringing the total in development to 48.
    [Show full text]
  • Integrated Control and Management of Neglected Tropical Skin Diseases
    POLICY PLATFORM Integrated Control and Management of Neglected Tropical Skin Diseases Oriol Mitjà1,2*, Michael Marks3,4, Laia Bertran1, Karsor Kollie5, Daniel Argaw6, Ahmed H. Fahal7, Christopher Fitzpatrick6, L. Claire Fuller8, Bernardo Garcia Izquierdo9, Roderick Hay8, Norihisa Ishii10, Christian Johnson11, Jeffrey V. Lazarus1, Anthony Meka12, Michele Murdoch13, Sally-Ann Ohene14, Pam Small15, Andrew Steer16, Earnest N. Tabah17, Alexandre Tiendrebeogo18, Lance Waller19, Rie Yotsu20, Stephen L. Walker3, Kingsley Asiedu6 1 Skin NTDs Program, Barcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain, 2 Division of Public Health, School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea, 3 Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom, 4 Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, United Kingdom, 5 Neglected Tropical and Non Communicable Diseases Program, Ministry of Health, Government of Liberia, Liberia, 6 Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland, a1111111111 7 The Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan, 8 International Foundation for a1111111111 Dermatology, London, United Kingdom, 9 Anesvad foundation, Bilbao, Spain, 10 Leprosy Research Center, a1111111111 National Institute of Infectious Diseases, Tokyo, Japan, 11 Fondation Raoul
    [Show full text]
  • Health of Men, Women, and Children in Post-Trafficking Services In
    Articles Health of men, women, and children in post-traffi cking services in Cambodia, Thailand, and Vietnam: an observational cross-sectional study Ligia Kiss, Nicola S Pocock, Varaporn Naisanguansri, Soksreymom Suos, Brett Dickson, Doan Thuy, Jobst Koehler, Kittiphan Sirisup, Nisakorn Pongrungsee, Van Anh Nguyen, Rosilyne Borland, Poonam Dhavan, Cathy Zimmerman Summary Background Traffi cking is a crime of global proportions involving extreme forms of exploitation and abuse. Yet little Lancet Glob Health 2015; research has been done of the health risks and morbidity patterns for men, women, and children traffi cked for various 3: e154–61 forms of forced labour. See Comment page e118 London School of Hygiene & Methods We carried out face-to-face interviews with a consecutive sample of individuals entering 15 post-traffi cking Tropical Medicine, London, UK (L Kiss PhD, C Zimmerman PhD, services in Cambodia, Thailand, and Vietnam. We asked participants about living and working conditions, experience N S Pocock MSc); International of violence, and health outcomes. We measured symptoms of anxiety and depression with the Hopkins Symptoms Organization for Migration, Checklist and post-traumatic stress disorder with the Harvard Trauma Questionnaire, and used adjusted logistic Bangkok, Thailand (D Thuy MA, regression models to estimate the eff ect of traffi cking on these mental health outcomes, controlling for age, sector of V A Nguyen MA, B Dickson BA, P Dhavan MPH, R Borland MA, exploitation, and time in traffi cking. N Pongrungsee, K Sirisup); International Organization for Findings We interviewed 1102 people, of whom 1015 reached work destinations. Participants worked in various sectors Migration, Phnom Penh, including sex work (329 [32%]), fi shing (275 [27%]), and factories (136 [13%]).
    [Show full text]
  • Philanthropic Foundations and Development Co-Operation
    Philanthropic Foundations and Development Co-operation Philanthropic Foundations and Development Co-operation Off-print of the DAC Journal 2003, Volume 4, No. 3 www.oecd.org Philanthropic Foundations and Development Co-operation Off-Print of the DAC Journal 2003, Volume 4, No. 3 Development Assistance Committee ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT Pursuant to Article 1 of the Convention signed in Paris on 14th December 1960, and which came into force on 30th September 1961, the Organisation for Economic Co-operation and Development (OECD) shall promote policies designed: – to achieve the highest sustainable economic growth and employment and a rising standard of living in member countries, while maintaining financial stability, and thus to contribute to the development of the world economy; – to contribute to sound economic expansion in member as well as non-member countries in the process of economic development; and – to contribute to the expansion of world trade on a multilateral, non-discriminatory basis in accordance with international obligations. The original member countries of the OECD are Austria, Belgium, Canada, Denmark, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, the United Kingdom and the United States. The following countries became members subsequently through accession at the dates indicated hereafter: Japan (28th April 1964), Finland (28th January 1969), Australia (7th June 1971), New Zealand (29th May 1973), Mexico (18th May 1994), the Czech Republic (21st December 1995), Hungary (7th May 1996), Poland (22nd November 1996), Korea (12th December 1996) and the Slovak Republic (14th December 2000).
    [Show full text]
  • Report Memoria
    Memoria2010Report Tu esfuerzo, nuestro compromiso Your effort, our commitment Las líneas de este gráfico muestran la evolución del índice de salud entre 1970 y 2010, según datos oficiales del PNUD. La línea azul representa a España; el resto corresponde a los países donde interviene Anesvad. The lines in this graph show the evolution of the health index between 1970 and 2010, according to official PNUD data. The blue line represents Spain; the rest shows countries in which Anesvad works. Redacción, Edición y Fotografías: Fundación Anesvad Diseño Gráfico: Koncepto Imprenta: Mcc Graphics Writing, Editing and Photography: Fundación Anesvad Graphic design: Koncepto Printing: Mcc Graphics Esta publicación está impresa en papel con Certificación Forestal (PEFC), garantizando que la materia prima para su fabricación proviene de bosques gestionados con criterios de sostenibilidad y uso racional. This publication is printed on paper with Forest Certification (PEFC), which guarantees that the raw materials come from sustainable forests. Al mismo tiempo, la empresa editora ha obtenido la Certificación de la Cadena de Custodia, mediante la cual garantiza el seguimiento de los materiales certificados desde el bosque hasta el producto final. The publisher also has the Custody Chain Certification, by which it guarantees tracing of raw materials from the forest to the final product. Los contenidos de esta publicación están sujetos a una licencia Creative Commons 3.0 Unported. Se permite su reproducción y difusión sin fines comerciales, siempre y cuando se cite la fuente. Cualquier alteración, transformación o derivación de esta obra sólo puede distribuirse bajo una licencia idéntica a ésta. Para ver una copia, visite http://creativecommons.org/licenses/ by-nc-sa/3.0/deed.es.
    [Show full text]
  • Transforming
    TRANSFORMING 2012 ANNUAL LIVES REPORT TRANSFORMING LETTER FROM OUR CEO 2012 ANNUAL Dear Friends of PCI, REPORT LIVES Despite the uncertainties of the economic environment in 2012, PCI closed CONTENTS the year on strong footing with our impact, programs and financial support OUR VISION all continuing to grow. This annual report highlights some of our continuing initiatives and most important priorities as we finished 2012 and look ahead Motivated by our concern for the world’s most vulnerable in our 2013-2016 Strategic Plan. children, families, and communi- ties, PCI envisions a world where abundant resources are shared, We’ve set a very ambitious goal: to reach and help transform the lives of ten communities are able to provide million people over the next three years. We know from all our experience that for the health and well-being of their members, and children even in the most disadvantaged circumstances people have the will and the 1LETTER FROM OUR CEO 12INTEGRATION IN ACTION can achieve lives of hope, good ability to change their own lives. When we provide the tools, training and health, and self-sufficiency. resources they need, they will lift themselves out of poverty and create a future of real hope, improved health and economic self-sufficiency for their families. OUR MISSION The stories in the following pages offer inspiring examples of personal, PCI’s mission is to prevent community and national transformational change that is occurring through- disease, improve community health, and promote sustainable out all our programs around the world. Our economic and social empowerment development worldwide.
    [Show full text]
  • Financial Report and Audited Financial Statements
    General Assembly A/71/5/Add.8 Official Records Seventy-first Session Supplement No. 5H United Nations Population Fund Financial report and audited financial statements for the year ended 31 December 2015 and Report of the Board of Auditors United Nations New York, 2016 Note Symbols of United Nations documents are composed of letters combined with figures. Mention of such a symbol indicates a reference to a United Nations document. ISSN 0257-0629 Contents Chapter Page Letters of transmittal ............................................................ 5 I. Report of the Board of Auditors on the financial statements: audit opinion ................ 7 II. Long-form report of the Board of Auditors .......................................... 9 Summary ...................................................................... 9 A. Mandate, scope and methodology ............................................. 13 B. Findings and recommendations ............................................... 14 1. Follow-up on previous recommendations ................................... 14 2. Financial overview ..................................................... 14 3. Internal control system .................................................. 16 4. Programme management ................................................ 18 5. Procurement management................................................ 21 6. Results-based management ............................................... 22 7. Human resources management ............................................ 23 8. Inventory management
    [Show full text]
  • Environmental and Behavioural Factors Associated with Mycobacterium Ulcerans Infection in the District of Lalo in Benin: a Case-Control Study
    Vol. 13(2), pp. 54-63 April-June 2021 DOI: 10.5897/JPHE2021.1306 Article Number: 78AAA5766467 ISSN 2141-2316 Copyright © 2021 Author(s) retain the copyright of this article Journal of Public Health and Epidemiology http://www.academicjournals.org/JPHE Full Length Research Paper Environmental and behavioural factors associated with Mycobacterium ulcerans infection in the district of Lalo in Benin: A case-control study Anagonou Gimatal Esaï1,7*, Sopoh Ghislain Emmanuel2, Biaou Chabi Alphonse1,2, Barogui Yves Thierry3,7, Wadagni Anita Carolle1,2, Gnimavo Sètondji Ronald2,4, Ayelo Gilbert Adjimon5, Saka Kora Eric1, Houezo Jean Gabin1 and Johnson Roch Christian6,7 1National Buruli Ulcer and Leprosy Control Program, Benin. 2Regional Institute of Public Health, Benin. 3Buruli Ulcer Screening and Treatment Center of Lalo, Benin. 4Buruli Ulcer and Leprosy Screening and Treatment Center, Raoul et Madeleine Follereau of Pobè, Benin. 5Buruli Ulcer Screening and Treatment Center of Allada, Benin. 6Foundation Raoul Follereau, Benin. 7Inter-Faculty Environmental Research Center for Sustainable Development, University of Abomey-Calavi, Benin. Received 21 January, 2021; Accepted 3 March, 2021 The mode of transmission of Buruli ulcer (BU) is not yet well understood. This study aimed to identify risk factors for BU in the district of Lalo in Benin. This is a case-control study taking into account all cases of BU detected from 2013 to 2018 and treated at the Buruli’s ulcer Screening and Treatment Center (CDTUB) of Lalo. For each case, two controls were matched according to age and sex. Conditional logistic regression was used to compare risk factors in cases and controls.
    [Show full text]
  • Exploitation, Violence, and Suicide Risk Among Child and Adolescent Survivors of Human Trafficking in the Greater Mekong Subregion
    Research Original Investigation Exploitation, Violence, and Suicide Risk Among Child and Adolescent Survivors of Human Trafficking in the Greater Mekong Subregion Ligia Kiss, PhD; Katherine Yun, MD; Nicola Pocock, MSc; Cathy Zimmerman, PhD Editorial at IMPORTANCE Human trafficking and exploitation of children have profound health jamapediatrics.com consequences. To our knowledge, this study represents the largest survey on the health of child and adolescent survivors of human trafficking. OBJECTIVE To describe experiences of abuse and exploitation, mental health outcomes, and suicidal behavior among children and adolescents in posttrafficking services. We also examine how exposures to violence, exploitation, and abuse affect the mental health and suicidal behavior of trafficked children. DESIGN, SETTING, AND PARTICIPANTS A survey was conducted with 387 children and adolescents aged 10 to 17 years in posttrafficking services in Cambodia, Thailand, or Vietnam, which along with Laos, Myanmar, and Yunnan Province, China, compose the Greater Melong Subregion. Participants were interviewed within 2 weeks of entering services from October 2011 through May 2013. MAIN OUTCOMES AND MEASURES Depression, posttraumatic stress disorder, anxiety, suicidal ideation, self-injury, and suicide attempts. RESULTS Among the 387 children and adolescent study participants, most (82%) were female. Twelve percent had tried to harm or kill themselves in the month before the interview. Fifty-six percent screened positive for depression, 33% for an anxiety disorder, and 26% for posttraumatic stress disorder. Abuse at home was reported by 20%. Physical violence while trafficked was reported by 41% of boys and 19% of girls. Twenty-three percent of girls and 1 boy reported sexual violence. Mental health symptoms were strongly associated with recent self-harm and suicide attempts.
    [Show full text]
  • Social Impact Report As an Exercise in Transparency with the Social Base and Society in General
    SOCIALLY RESPONSIBLE INVESTMENT SOCIAL IMPACT ANESVAD REPORT DECEMBER 2018 DETERMINANTES DE LA SALUD SUMMARY 03 ABOUT US AND OUR WORK 04 COMMITMENT TO SOCIAL IMPACT INVESTMENTS CLASSIFIED 08 ACCORDING TO THE SUSTAINABLE DEVELOPMENT GOALS (SDGs) INVESTMENT PORTFOLIO 10 ANALYSIS, ACCORDING TO ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) CRITERIA 12 MEASURING SOCIAL IMPACT 16 SUCCESS STORIES COLLECTION OF DATA USED IN THIS REPORT We would like to thank all the fund managers who make the effort to publish an impact report regarding their funds and who have facilitated the collection of the data used in this report. The data were collected during the months of May and June 2019 and correspond to the period from January 1st to December 31st, 2018. In cases where there was no impact report for the indicated period we have used the data from the previous report published. ABOUT US AND OUR WORK At Anesvad we fight against the neglected diseases that threaten millions of people’s lives in Sub-Saharan Africa. Buruli ulcer, leprosy, yaws, and lymphatic filariasis are the four Neglected Tropical Diseases (NTDs) that form the basis of our work. The manifestation of these four NTDs share similarities: it occurs via the skin, becoming extremely aggressive and sometimes resulting in life-long disability. However, the physical marks are not the only lasting consequences for those who 2018 manage to overcome these diseases: they also lead to stigmatisation, social and occupational exclusion and diminished self-esteem. At Anesvad we pool our efforts and we are therefore aligned with the World Health Organisation’s 2020 Road Map.
    [Show full text]